Remote Jobs at Alentis Therapeutics

Alentis Therapeutics

51 - 200 employees

Founded 2019

🧬 Biotechnology

💊 Pharmaceuticals

🏥 Healthcare

💰 $181.4M Series D on 2024-11

Biotechnology • Pharmaceuticals • Healthcare

Alentis Therapeutics is a clinical-stage biotechnology company (headquartered in Allschwil, Switzerland) developing anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies to treat cancer and reverse organ fibrosis. Their pipeline includes clinical candidates such as ADC ALE. P02 for squamous cancers, ALE. P03, and the monoclonal antibody lixudebart (ALE. F02) for fibrosis; they emphasize targeted anti-Claudin-1 modalities to open stiff extracellular matrix, block disease signaling, and selectively kill tumor cells.